Fuchs, Bryan C <br/><br/>
Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.  [electronic resource] 

 -  Hepatology (Baltimore, Md.)  Apr 2014 
 - 1577-90 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-3350 
<br/><br/><label>Standard No.: </label>10.1002/hep.26898  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Bile Ducts--physiopathology<br/>Carbon Tetrachloride--adverse effects<br/>Carcinoma, Hepatocellular--pathology<br/>Cell Proliferation--drug effects<br/>Cells, Cultured<br/>Diethylnitrosamine--adverse effects<br/>Disease Models, Animal<br/>Disease Progression<br/>ErbB Receptors--antagonists & inhibitors<br/>Erlotinib Hydrochloride<br/>Hepatic Stellate Cells--drug effects<br/>Hepatocytes--drug effects<br/>Humans<br/>Ligation--adverse effects<br/>Liver Cirrhosis--etiology<br/>Liver Neoplasms--pathology<br/>Male<br/>Mice<br/>Mice, Inbred Strains<br/>Phosphorylation--drug effects<br/>Prognosis<br/>Quinazolines--pharmacology<br/>Rats<br/>Rats, Wistar<br/>Transcriptome